Replacing traditional brand management with multichannel interaction
Graham McIntosh, Managing Director of Commercial & Clinical Pharma, at Uniphar Group plc looks at how the traditional brand management approach isn’t working anymore...
Tillotts Pharma UK embracing partnerships
Jeremy Thorpe is Managing Director of Tillotts Pharma UK Ltd. In his seven years at the helm, he has seen continuous double-digit growth and...
Setting up a menopause support group
Angela Bandeira of Northumbria Healthcare Foundation Trust shares her experience of setting up a menopause support group. Why did you want to set up a...
Implementing Agile working in pharma
Neil Osmond asks whether the Agile mindset and approach to managing projects could solve the pharmaceutical industry’s productivity problem and discusses the benefits of...
Engaging patients earlier in clinical development
Successful patient engagement is essential to the clinical development process. How can companies get it right? Patient and public engagement in clinical research means that...
The five legal pitfalls of clinical trial agreements
Sarah Lynam discusses the five legal pitfalls of clinical trial agreements. Collaboration between pharmaceutical companies, research organisations and hospital trusts, and the resulting clinical trials...
Supporting First Line Field Managers in Pharma
Ian Robinson discusses how to provide structure to sequential in-call coaching to enhance customer excellence when supporting First Line Field Managers in pharma. In the...
What will 2D matrix coding achieve for the pharma industry?
Tony Cordrey is Vice President of European Strategic Operations at Accord Healthcare. Having been at the forefront of the Falsified Medicines Directive (FMD) rollout,...
Antimicrobial resistance: Innovation must go hand-in-hand with awareness
Paul Chapman discusses antimicrobial resistance and how innovation must go hand-in-hand with awareness to combat superbugs. A recent study from researchers at Glasgow Caledonian University warned...
How pharma can prepare for Brexit
John Leyden shares his basic steps for how pharma can prepare for Brexit. I realise that most of us, including me, are getting tired of...
Latest articles
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Digital interventions for behaviour change
New NICE guidance looks at digital interventions for behaviour change and suggests that these interventions such as apps, wearable devices and online programmes and...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...
Popular articles
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
What’s been authorised? UK, Europe, US drug approvals
Pf summarises the UK, Europe and US drug approvals from 20 - 24 Jan 2020. UK The National Institute for Health and Care Excellence published draft...
Key publications to impact the UK access environment in 2020
Craig Bradley, Commercial Lead Rare GI at Takeda, PM Society Chair & PM Society Market Access Interest Group Lead, looks at key publications to...
Tiofarma admits illegal role in fludrocortisone anti-competitive agreement
Tiofarma has admitted that it took part in a fludrocortisone anti-competitive agreement that resulted in significant price hikes for the essential medicine. This means that...
Acute aortic dissection is a ‘ticking time bomb’
Safety body calls for earlier recognition of ‘ticking time bomb’ aortic dissection to prevent deaths as its new report reveals that up to half...